Clinical Trials Browser

Phase 2 × toripalimab × Other solid neoplasm × Clear all

NCT07480733 2026-03-18

A Phase II Clinical Study Evaluating the Safety, Tolerability,Pharmacokinetics, and Preliminary Efficacy of JS212 andJS213 as Monotherapy and in Combination in Patients Withadvanced Malignant Solid Tumors

Phase 2 Not yet recruiting

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT06873854 2025-03-13

A Study of LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours

Phase 2 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT06490068 2024-07-08

Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy

Phase 2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT04301557 2024-04-23

PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer

Phase 2 Active not recruiting

GastrointestinalOther solid neoplasm

DMMR Colorectal Cancer

NCT04713761 2021-01-26

Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant